Marzetti (MZTI) Form 4: CFO Receives 2,241 Restricted Stock Units
Rhea-AI Filing Summary
Thomas K. Pigott, a vice president, chief financial officer and assistant secretary of The Marzetti Company (MZTI), reported an insider transaction dated 08/12/2025. The Form 4 shows Pigott was issued 2,241 restricted stock units (RSUs), each representing a contingent right to one share of common stock. The RSUs carry an exercise/issuance price of $0.0000 and are shown as directly beneficially owned following the grant.
The RSUs vest or are payable on 08/12/2028 (same date listed for exercisable and expiration), and the filing was signed by an attorney-in-fact on 08/14/2025. The filing contains no information about cash consideration, performance conditions, or the overall impact on outstanding shares.
Positive
- 2,241 RSUs granted to the reporting officer, providing direct alignment of management and shareholder interests
- Each RSU converts to one share (explicit explanation provided), clarifying the economic instrument
Negative
- Vesting/issuance not immediate—RSUs are set for 08/12/2028, introducing multi-year timing before share issuance
- No disclosure of performance conditions or aggregate dilution in the filing, limiting assessment of material impact
Insights
TL;DR: Routine executive equity grant: small RSU award reported by the CFO, typical for compensation alignment.
The Form 4 documents a non-derivative grant of 2,241 RSUs to the reporting officer on 08/12/2025 that convert one-for-one into common shares on 08/12/2028. The award is reported as directly beneficially owned and shows a $0.0000 price, consistent with restricted awards rather than open-market purchases. This appears to be a standard time-based equity award and, absent additional disclosure on vesting conditions or company-wide dilution, is likely immaterial to capital structure in isolation.
TL;DR: Governance-normal issuance: a multi-year RSU grant to a senior officer, documented via Form 4.
The filing confirms the reporting person holds the title VP, CFO and Assistant Secretary and received 2,241 RSUs subject to issuance on 08/12/2028. The signature by an attorney-in-fact is provided. The disclosure is straightforward and follows Section 16 reporting norms. The filing does not disclose committee approval, performance conditions, or aggregation with other awards, limiting assessment of governance implications beyond routine compensation reporting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 2,241 | $0.00 | $0.00 |
Footnotes (1)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.